I think the price should be between $8 to $10.There technology works other wise they would not have spent an additional $50 million plus royalties for the late phase trials for gvd and Cronhs desease.They know there stuff and would have fully researched its potential.
manipulation rife on asx say researchers, page-7
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.60 |
Change
0.025(1.59%) |
Mkt cap ! $1.832B | |||
| Open | High | Low | Value | Volume |
| $1.65 | $1.65 | $1.59 | $6.717M | 4.158M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 8977 | $1.76 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.50 | 4000 | 1 |
View Market Depth
| Last trade - 15.59pm 19/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |